6JT3 image
Entry Detail
PDB ID:
6JT3
Keywords:
Title:
Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2019-04-08
Release Date:
2019-10-30
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Beta-secretase 1
Chain IDs:A
Chain Length:416
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Discovery of an Extremely Potent Thiazine-Based beta-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose.
J.Med.Chem. 62 9331 9337 (2019)
PMID: 31549838 DOI: 10.1021/acs.jmedchem.9b01140

Abstact

Genetic evidence points to deposition of amyloid-β (Aβ) as a causal factor for Alzheimer's disease. Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein. Starting with an oxazine lead 1, we describe the discovery of a thiazine-based BACE1 inhibitor 5 with robust Aβ reduction in vivo at low concentrations, leading to a low projected human dose of 14 mg/day where 5 achieved sustained Aβ reduction of 80% at trough level.

Legend

Protein

Chemical

Disease

Primary Citation of related structures